A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...
J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...
Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to immunosuppression and cancer ...
Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has announced a new Phase 2 clinical study designed to evaluate ...
3don MSN
Gut bacteria from amphibians and reptiles achieve complete tumor elimination in preclinical model
A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST) has discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese ...
2don MSN
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...
The Mid-South health system identified over twice as many incidental pulmonary nodules, half of which were in a higher-risk ...
AZmed, one of the leading companies in artificial intelligence (AI) for radiology, announced today the CE marking of AZnod, ...
What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...
Changing just one atom in a COVID-19 vaccine lipid redirects delivery from the liver to the spleen, improving tumor ...
A systematic review of 17 randomized trials found that among high cardiovascular risk individuals, reducing saturated fat was linked to lower all-cause mortality and possible reductions in ...
News-Medical.Net on MSN
Frog-derived bacteria offer dual-action anticancer effects and high safety
A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST) has discovered that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results